查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451503

2024-2032 年按疾病类型、治疗类型、药物类别、配销通路和地区分類的甲真菌病治疗市场报告

Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球甲癣治疗市场规模达到35亿美元。展望未来， IMARC Group预计到2032年市场规模将达到52亿美元，2024-2032年复合年增长率（CAGR）为4.6%。

甲真菌病是一种发生在手指甲和脚趾甲的真菌感染，可导致不适、慢性疼痛和毁容。近端甲下、白色表浅和远端甲下是甲真菌病的一些类型。它是脚气患者常见的指甲感染，由多种微生物引起，如皮癣菌、酵母菌和非皮癣菌霉菌。甲真菌病的症状包括指甲形状扭曲、恶臭、颜色从白色到黄棕色、指甲质地脆、粗糙且易碎。通常透过剪下的指甲和指甲活检进行钾、氧和氢 (KOH) 检查、培养和组织病理学检查来诊断，并透过雷射疗法、药物和光动力疗法进行治疗。

甲真菌病治疗市场趋势：

甲癣、人类免疫缺陷病毒（HIV）、糖尿病和周边动脉疾病（PAD）等慢性疾病的盛行率不断上升，是推动市场成长的关键因素之一。此外，老年人口的增加极易出现循环系统疾病和免疫系统减弱，也推动了市场的成长。由于更多接触公共游泳池以及穿着紧身、受污染或弄脏的衣服、鞋子和袜子，甲癣在千禧世代和成年人中也非常普遍。此外，可口服的水溶性抗真菌治疗溶液的开发也推动了市场的成长。它们有助于预防继发细菌感染并防止真菌生长。其他因素，包括广泛使用外用指甲油和药膏来保持指甲卫生，以及医疗基础设施的显着改善，预计将推动市场成长。

本报告回答的关键问题

  • 2023年全球甲癣治疗市场规模有多大？
  • 2024-2032年全球甲癣治疗市场的预期成长率是多少？
  • 推动全球甲癣治疗市场的关键因素是什么？
  • COVID-19 对全球甲癣治疗市场有何影响？
  • 根据疾病类型，全球甲癣治疗市场的细分情况如何？
  • 根据治疗类型，全球甲癣治疗市场的细分情况如何？
  • 基于配销通路，全球甲癣治疗市场的细分情况如何？
  • 全球甲癣治疗市场的关键地区有哪些？
  • 全球甲癣治疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球甲癣治疗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依疾病类型

  • 远端甲下甲癣
    • 市场走向
    • 市场预测
  • 近端甲下甲癣
    • 市场走向
    • 市场预测
  • 白色浅层甲癣
    • 市场走向
    • 市场预测
  • 念珠菌性甲癣
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依治疗类型

  • 雷射治疗
    • 市场走向
    • 市场预测
  • 光动力疗法
    • 市场走向
    • 市场预测
  • 药物治疗
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依药物类别

  • 烯丙胺
    • 市场走向
    • 市场预测
  • 唑类
    • 市场走向
    • 市场预测
  • 灰黄霉素
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按配销通路

  • 医院和诊所
    • 市场走向
    • 市场预测
  • 网上商店
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Bausch Health Companies Inc.
    • Cipla Limited
    • Dr. Reddy's Laboratories
    • Galderma SA
    • GlaxoSmithKline PLC
    • Kaken Pharmaceutical Co. Ltd
    • Lumenis Ltd
    • Moberg Pharma AB
    • Novartis AG
    • Pfizer Inc.
    • The OTC Lab BV
Product Code: SR112024A4877

The global onychomycosis treatment market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.

Onychomycosis is a fungal infection that occurs in the fingernails and toenails that can lead to discomfort, chronic pain and disfigurement. Proximal subungual, white superficial and distal subungual are some of the types of onychomycosis. It is a common nail infection in patients with athlete's foot and is caused by various organisms, such as dermatophytes, yeasts and non-dermatophyte molds. Onychomycosis is characterized by symptoms, including distortion in the shape of nails, foul smell, whitish to yellow-brown discoloration and brittle, ragged and crumbly texture of the nails. It is usually diagnosed through potassium, oxygen and hydrogen (KOH) examination, culture and histopathological examinations of nail clippings and nail biopsies and is treated through laser therapy, drugs and photodynamic therapies.

Onychomycosis Treatment Market Trends:

The increasing prevalence of chronic medical ailments, such as onychomycosis, human immunodeficiency virus (HIV), diabetes and peripheral artery disease (PAD), is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is highly prone to circulatory disorders and weakened immune system, is providing a thrust to the market growth. Onychomycosis is also highly prevalent among millennials and adults due to the increased exposure to public swimming pools and utilization of tight, contaminated or soiled clothes, shoes and socks. Additionally, the development of water-soluble antifungal treatment solutions that can be administered orally is providing a thrust to the market growth. They aid in preventing secondary bacterial infections and prevent the growth of fungus. Other factors, including the widespread utilization of topical nail lacquers and ointments to maintain nail hygiene, along with the significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global onychomycosis treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on disease type, treatment type, drug class and distribution channel.

Breakup by Disease Type:

Distal Subungual Onychomycosis

Proximal Subungual Onychomycosis

White Superficial Onychomycosis

Candidal Onychomycosis

Others

Breakup by Treatment Type:

Laser Therapy

Photodynamic Therapy

Drug Treatment

Breakup by Drug Class:

Allylamine

Azole

Griseofulvin

Others

Breakup by Distribution Channel:

Hospitals and Clinics

Online Stores

Retail Pharmacies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories, Galderma SA, GlaxoSmithKline PLC, Kaken Pharmaceutical Co. Ltd, Lumenis Ltd, Moberg Pharma AB, Novartis AG, Pfizer Inc. and The OTC Lab B.V.

Key Questions Answered in This Report

  • 1. What was the size of the global onychomycosis treatment market in 2023?
  • 2. What is the expected growth rate of the global onychomycosis treatment market during 2024-2032?
  • 3. What are the key factors driving the global onychomycosis treatment market?
  • 4. What has been the impact of COVID-19 on the global onychomycosis treatment market?
  • 5. What is the breakup of the global onychomycosis treatment market based on the disease type?
  • 6. What is the breakup of the global onychomycosis treatment market based on the treatment type?
  • 7. What is the breakup of the global onychomycosis treatment market based on the distribution channel?
  • 8. What are the key regions in the global onychomycosis treatment market?
  • 9. Who are the key players/companies in the global onychomycosis treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Onychomycosis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disease Type

  • 6.1 Distal Subungual Onychomycosis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Proximal Subungual Onychomycosis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 White Superficial Onychomycosis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Candidal Onychomycosis
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Laser Therapy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Photodynamic Therapy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Drug Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Drug Class

  • 8.1 Allylamine
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Azole
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Griseofulvin
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Online Stores
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Retail Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bausch Health Companies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Cipla Limited
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Dr. Reddy's Laboratories
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Galderma SA
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 GlaxoSmithKline PLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Kaken Pharmaceutical Co. Ltd
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Lumenis Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 SWOT Analysis
    • 15.3.8 Moberg Pharma AB
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 The OTC Lab B.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Onychomycosis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Onychomycosis Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Onychomycosis Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Onychomycosis Treatment Market: Breakup by Disease Type (in %), 2023
  • Figure 5: Global: Onychomycosis Treatment Market: Breakup by Treatment Type (in %), 2023
  • Figure 6: Global: Onychomycosis Treatment Market: Breakup by Drug Class (in %), 2023
  • Figure 7: Global: Onychomycosis Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Onychomycosis Treatment Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Onychomycosis Treatment (Other Disease Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Onychomycosis Treatment (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Onychomycosis Treatment (Laser Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Onychomycosis Treatment (Laser Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Onychomycosis Treatment (Photodynamic Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Onychomycosis Treatment (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Onychomycosis Treatment (Drug Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Onychomycosis Treatment (Drug Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Onychomycosis Treatment (Allylamine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Onychomycosis Treatment (Allylamine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Onychomycosis Treatment (Azole) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Onychomycosis Treatment (Azole) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Onychomycosis Treatment (Griseofulvin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Onychomycosis Treatment (Griseofulvin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Onychomycosis Treatment (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Onychomycosis Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Onychomycosis Treatment (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Onychomycosis Treatment (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Onychomycosis Treatment (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Onychomycosis Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Onychomycosis Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Onychomycosis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Onychomycosis Treatment (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Onychomycosis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: North America: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: North America: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: United States: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: United States: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Canada: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Canada: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Asia-Pacific: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Asia-Pacific: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: China: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: China: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Japan: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Japan: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: India: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: India: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: South Korea: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: South Korea: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Australia: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Australia: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Indonesia: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Indonesia: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Europe: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Europe: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Germany: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Germany: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: France: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: France: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: United Kingdom: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: United Kingdom: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Italy: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Italy: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Spain: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Spain: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Russia: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Russia: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Latin America: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Latin America: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Brazil: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Brazil: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Mexico: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Mexico: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Others: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Middle East and Africa: Onychomycosis Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Middle East and Africa: Onychomycosis Treatment Market: Breakup by Country (in %), 2023
  • Figure 89: Middle East and Africa: Onychomycosis Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Global: Onychomycosis Treatment Industry: SWOT Analysis
  • Figure 91: Global: Onychomycosis Treatment Industry: Value Chain Analysis
  • Figure 92: Global: Onychomycosis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Onychomycosis Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Onychomycosis Treatment Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
  • Table 3: Global: Onychomycosis Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 4: Global: Onychomycosis Treatment Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 5: Global: Onychomycosis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Onychomycosis Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Onychomycosis Treatment Market: Competitive Structure
  • Table 8: Global: Onychomycosis Treatment Market: Key Players